MyelomA genetics international consortium

Gareth Morgan, Hans Johnsen, Hartmut Goldschmidt, Antonio Palumbo, Michele Cavo, Pieter Sonneveld, Jesus Migel, Char Sang Chim, Paul Browne, Hermann Einsele, Anders Waage, Ingemar Turesson, Andrew Spencer, Roman Hajek, Heinz Ludwig, Kari Hemminki, Richard Houlston

    Research output: Contribution to journalArticleResearchpeer-review

    8 Citations (Scopus)


    While the etiology of multiple myeloma (MM) is largely unknown, evidence for an inherited genetic susceptibility is provided by the two-fold increased risk of the disease seen in first-degree relatives of cases of MM. It is likely that part of this heritable risk is a consequence of the co-inheritance of low-risk genetic variants. The accumulated experience to date in identifying risk variants for other tumors has highlighted difficulties in conducting statistically and methodologically rigorous studies. The MyelomA Genetics International Consortium (MAGIC) includes 16 research groups in Europe, Asia, Australasia, the Middle East and the Americas engaged in studying the genetics of MM. The first goal of MAGIC is to identify and characterize common genetic variants for MM through association-based analyses. Here, we review the rationale for identifying genetic risk variants for MM and our proposed strategy for establishing MAGIC. A? 2012 Informa UK, Ltd.
    Original languageEnglish
    Pages (from-to)796 - 800
    Number of pages5
    JournalLeukemia and Lymphoma
    Issue number5
    Publication statusPublished - 2012

    Cite this